FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...

Disc Medicine eyes standard US approval for drug after FDA denies fast-track nod

By Siddhi Mahatole Feb 17 (Reuters) - Disc Medicine said on Tuesday it will pursue a traditional U.S. approval pathway for ...
The New England Journal of Medicine

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered ...

Should Drug Companies Be Advertising to Consumers?

Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are ...